Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts-Reference-Cited by-同舟云学术

Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts

Published:2015-01-26 Issue:4 Volume:50 Page:493-498
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Hobbs G S,Hamdi A,Hilden P D,Goldberg J D,Poon M L,Ledesma C,Devlin S M,Rondon G,Papadopoulos E B,Jakubowski A A,O'Reilly R J,Champlin R E,Giralt S,Perales M-A,Kebriaei P

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2014302.pdf

Reference22 articles.

1. Fielding AK, Goldstone AH . Allogeneic haematopoietic stem cell transplant in Philadelphia-positive acute lymphoblastic leukaemia. Bone Marrow Transplant 2008; 41: 447–453.

2. Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 2008; 111: 1827–1833.

3. Thomas X, Boiron JM, Huguet F, Dombret H, Bradstock K, Vey N et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 2004; 22: 4075–4086.

4. Goldberg JD, Linker A, Kuk D, Ratan R, Jurcic J, Barker JN et al. T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease. Biol Blood Marrow Transplant 2013; 19: 208–213.

5. Kebriaei P, Saliba R, Rondon G, Chiattone A, Luthra R, Anderlini P et al. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes. Biol Blood Marrow Transplant 2012; 18: 584–592.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?;Hematology;2024-04-10

2. Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation;Bone Marrow Transplantation;2024-02-13

3. Acute graft-versus-host disease;Nature Reviews Disease Primers;2023-06-08

4. Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation;Blood Advances;2022-11-22

5. Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice;Transplantation and Cellular Therapy;2022-08